Home SicaGene

SicaGene

In operation
Equity Financing
Oligonucleotide Drug Developer
Basic
Enterprise Profile

Basic Information

SicaGene is a biotechnology company focusing on the research and development of a new generation of single-stranded oligonucleotide (ASO) drugs. The team brings together senior experts from internationally renowned biotechnology companies such as BeiGene and Ionis, possessing extensive experience in oligonucleotide drug R&D, clinical trials, and industrial transformation. It has obtained key qualifications including "National High-tech Enterprise," "Zhongguancun High-tech Enterprise," and "Specialized, Precise, Unique and Innovative Small and Medium-sized Enterprise." The team has been honored with titles such as the National High-level Talent Special Support Program - "Ten Thousand Talents Plan" leading scientific and technological talent, Beijing Daxing District New Gateway Youth Talent, and the Most Innovative Award at the 10th "Dongsheng Cup" International Entrepreneurship Competition.
SicaGene (Beijing) Biotechnology Co., Ltd.
Beijing,China
15~50 people
November 15, 2021
BD@sicagene.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Concept
Cardiovascular Disease # Nervous System Diseases Rare Diseases
Application Scenarios
Innovative Drugs Nucleic Acid Drugs Small Nucleic Acid Drugs